Harvard-Affiliated Cancer Center Retracts Several Studies

Dana-Farber Cancer Institute Building

The Dana-Farber Cancer Institute retracted seven studies and is investigating multiple researchers after allegations were made that images had been manipulated or duplicated, according to NBC News.

Dr. Sholto David, a molecular biologist, investigated in January multiple studies from top researchers within the institute, which is a teaching affiliate of Harvard Medical School, and concluded that several images had possibly been manipulated by software such as Adobe Photoshop, according to The Wall Street Journal. The institute originally said they were retracting six studies but have added a seventh, while also requesting corrections in an additional 31 papers, according to NBC News.

Read the full story

Harvard Medical School Affiliate Looks to Retract Multiple Studies, Correct Papers

Dana-Farber Cancer Institute

A Harvard Medical School affiliate is planning to retract six studies and correct 31 papers due to an ongoing investigation into several senior cancer researchers and administrators, according to The Wall Street Journal.

The investigation involves more than 50 papers, four of which are co-authored by Dana-Farber Cancer Institute CEO and President Dr. Laurie Glimcher, according to the WSJ. The institute has not determined whether research misconduct occurred, although several requests for retractions and corrections have been sent to journals.

Read the full story